RecruitingACTRN12606000371594

Take Heart in Primary Care Study

A cluster randomised controlled trial designed to investigate the impact on the prevalence and severity of depression, in patients with chronic manifestations of ischaemic heart disease.


Sponsor

NHMRC

Enrollment

604 participants

Start Date

Sep 18, 2006

Study Type

Interventional

Conditions

Summary

Heart disease is Australia's biggest health problem, affecting nearly 3.7 million people every year. Recent research has shown that emotional problems such as depression can make heart problems worse. However, it is often difficult to diagnose depression in people with heart problems. This research aims to improve the general health and wellbeing of people with chronic heart problems and depression by determining whether a special general practitioner enhanced education program, comprising the monitoring of depression, academic detailing of best-practice guidelines and psychiatric advice to the treating GP, will reduce depression in people with chronic heart probalems.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 85 Yearss

Plain Language Summary

Simplified for easier understanding

This study is looking at how to better help patients with ischaemic heart disease (where the arteries supplying the heart become narrowed) who also have depression. Depression is very common in people with heart disease and can make their heart condition worse and harder to manage. This study tests a special program for GPs (family doctors) that helps them recognise and treat depression in their heart patients using best-practice guidelines and specialist psychiatric advice. The goal is to see whether patients under the care of GPs enrolled in this program have less depression and better overall health. You may be eligible if: - You are between 18 and 85 years old - You have been diagnosed with ischaemic heart disease in the past 6 months and continue to need ongoing management (such as for chest pain or heart failure) - You attend a participating general practice in South Australia - You can speak and understand English - You have intact thinking and memory (cognitive function) - You are willing to give informed consent You may NOT be eligible if: - You have a psychotic illness or communication problem that prevents you talking with your GP - You are about to have heart surgery or a transplant that would change your condition - You have been hospitalised for a heart-related reason in the past 3 months Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A comprehensive three-part program of: 1)screening for depression in primary care patients requiring ongoing management of chronic manifestations of ischaemic heart disease; 2) academic detailing of b

A comprehensive three-part program of: 1)screening for depression in primary care patients requiring ongoing management of chronic manifestations of ischaemic heart disease; 2) academic detailing of best-practice guidelines for managing depression; and 3) patient-specific psychiatric advice to the treating GP with follow-up screening and advice, relative to usual GP management. Duration of study: 12 months. Depression will be determined via the Centre for Epidemiologic Studies-Depression Scale (CES-D) and the Arroll (2 question) scale. All study patients will be screened at baseline and 12 months. Patients in the intervention group, and depressed, will be rescreened at 3, 6 and 9 months as required.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000371594